Sales and Marketing

Showing 15 posts of 11464 posts found.

Maze Therapeutics and Sanofi sign exclusive worldwide license agreement for Pompe disease treatment

May 3, 2023 Sales and Marketing License Agreement, Pompe disease, Rare Diseases, Sanofi, maze therapeutics, treatment

Maze Therapeutics and Sanofi have announced that they have signed an exclusive worldwide license agreement for Maze’s gluogen synthase 1 …

FDA approves Pfizer’s pneumococcal conjugate vaccine for infants and children

April 28, 2023 Market Access, Research and Development, Sales and Marketing Ear Nose & throat, FDA, Immunology, Pfizer, Vaccine, pneumococcal vaccine

Pfizer has announced that the US Food and Drug Administration (FDA) has approved its PREVNAR 20 (20-valent pneumococcal conjugate vaccine) …

PANTHERx Rare announces release of treatment for rare stable Wilson Disease

April 20, 2023 Sales and Marketing

US-based rare medicines pharmacy PANTHERx Rare has announced the launch of Cuvrior, a treatment for stable Wilson Disease in adults …

Acadia Pharmaceuticals announces commercialisation of Daybue for Rett syndrome

April 19, 2023 Sales and Marketing

Acadia Pharmaceuticals has announced that Daybue (trofinetide) is now available for adult and paediatric patients over the age of two …

Ariceum Therapeutics announces extension of Series A financing for radiopharmaceutical clinical pipeline

April 18, 2023 Sales and Marketing

Private biotech company Ariceum Therapeutics has announced the successful completion of Series A extension financing, raising an additional €22.75m following …

Merck acquires Prometheus Biosciences, strengthens immunology pipeline

April 17, 2023 Sales and Marketing

Merck (known as MSD outside of the US and Canada) has announced that it, through a subsidiary, has agreed to …

Neuromod closes €30m financing for new tinnitus treatment device

April 14, 2023 Sales and Marketing

Irish medical device company Neuromod has announced that it has successfully closed a €30m financing intended to further commercialise Lenire, …

Adcendo ApS to Present Data on the Expression of the Novel ADC target uPARAP in Soft Tissue and Bone Sarcoma at the 2023 American Association for Cancer Research (AACR) Annual Meeting

April 13, 2023 Sales and Marketing

Copenhagen, Denmark, 13 April, 2023 – Adcendo ApS (“Adcendo”), a biotech company focused on the development of breakthrough antibody-drug conjugates (ADCs) …

Alentis Therapeutics closes $105m Series C funding for new treatment options

April 13, 2023 Sales and Marketing

Alentis Therapeutics has announced $105m in Series C funding which was led by Jeito Capital together with Novo Holdings A/S …

ImaginAb signs new license and supply agreement with Leucid Bio for CD8 ImmunoPET technology

April 12, 2023 Sales and Marketing

Biotechnology company ImaginAb has announced that it has signed a new non-exclusive License and Supply Agreement (LSA) with Leucid Bio. …

Théa Open Innovation and Galimedix announce partnership for development and commercialisation of GAL-101

April 3, 2023 Sales and Marketing

Théa Open Innovation (TOI) and Galimedix have announced that they have signed a licensing agreement granting TOI exclusive rights for …

Alzheimer’s drug Leqembi expected to generate $12.9bn in sales by 2028

March 30, 2023 Sales and Marketing

After receiving FDA approval in January 2023, Biogen/Eisai’s new Alzheimer’s disease Leqembi is expected to become a blockbuster, with a …

PureTech Health and Royalty Pharma enter KarXT royalty agreement up to $500m

March 23, 2023 Sales and Marketing

Royalty Pharma have acquired a $500m interest in PureTech’s royalty in Karuna Therapeutics’ KarXT, with $100m cash up front and …

BioNTech and OncoC4 to partner for development and commercialisation of novel checkpoint antibody

March 21, 2023 Sales and Marketing

BioNTech and OncoC4 have entered a strategic collaboration for the co-development and commercialisation of a novel checkpoint antibody for multiple …

Sun Pharma settles at $75m in industry-wide price-fixing case

March 17, 2023 Sales and Marketing

Sun Pharma has decided a settlement of $75m as part of a case surrounding various pharma companies fixing their prices. …

Latest content